Skip to main content

Dr. Dima Dandachi, M.D

Internal Medicine (Internal Medicine Physician)

  • Medicare participating

At a glance

Years since graduation
20
In the NPI registry since
2012
Medicare patients seen, 2024
34

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2012Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Internal Medicine Physician primary
    MO license 2018016511
  • Student in an Organized Health Care Education/Training Program
    IL license 036138486

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Internal Medicine per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
34
Services billed
84
Patients’ average age
60
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes6047

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Shingrix (varicella-zoster ge/as01b/pf)
Other prescribers in Columbia, MO
40
Abrysvo (rsv vacc, pref a and pref b/pf)
Other prescribers in Columbia, MO
37
Boostrix Tdap (diphth,pertuss(acell),tet vac)
Other prescribers in Columbia, MO
28
Biktarvy (bictegrav/emtricit/tenofov ala)15
Dovato (dolutegravir sodium/lamivudine)13

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 2 companies reported 109 payments worth $92,742 in total to this clinician.

By type
Compensation for services other than consulting (speaking, faculty)$68,360
Travel and Lodging$12,955
Consulting Fee$8,355
Food and Beverage$3,072

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jun 2, 2025Viiv Healthcare Company
Jun 2, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$7,150
Nov 24, 2025Viiv Healthcare Company
Nov 24, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$7,150
Apr 21, 2025Gilead Sciences, Inc.
Apr 21, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4027423;GTF;11356658
$6,750
Aug 12, 2025Gilead Sciences, Inc.
Aug 12, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4176334;AHM;11356658
$5,020
Dec 16, 2025Gilead Sciences, Inc.
Dec 16, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s description;4269560;AHM;11356658
$5,020
Sep 10, 2025Viiv Healthcare Company
Sep 10, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$3,900
Mar 18, 2025Gilead Sciences, Inc.
Mar 18, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4113469;AHM;11356658
$3,840
Sep 9, 2025Gilead Sciences, Inc.
Sep 9, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4259721;AHM;11356658
$3,840
Feb 10, 2025Gilead Sciences, Inc.
Feb 10, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4113475;AHM;11356658
$2,950
Oct 8, 2025Gilead Sciences, Inc.
Oct 8, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s description;4264060;AHM;11356658
$2,950
All 60 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 19, 2025Gilead Sciences, Inc.
Dec 19, 2025
Travel and Lodging
travel to Los Angeles, CA · in-kind
Company’s description;4269114;AHM;11356658
$202
Dec 19, 2025Gilead Sciences, Inc.
Dec 19, 2025
Travel and Lodging
travel to Los Angeles, CA · in-kind
Company’s description;4268733;AHM;11356658
$60.00
Dec 16, 2025Gilead Sciences, Inc.
Dec 16, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s description;4269560;AHM;11356658
$5,020
Dec 2, 2025Gilead Sciences, Inc.
Dec 2, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4261854;AHM;11356658
$2,065
Dec 2, 2025Gilead Sciences, Inc.
Dec 2, 2025
Travel and Lodging
travel to Los Angeles, CA · in-kind
Company’s description;4327826;AHM;11356658
$1,261
Nov 24, 2025Viiv Healthcare Company
Nov 24, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$7,150
Nov 24, 2025Viiv Healthcare Company
Nov 24, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$1,300
Nov 20, 2025Gilead Sciences, Inc.
Nov 20, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4286402;GTF;11356658
$590
Nov 20, 2025Gilead Sciences, Inc.
Nov 20, 2025
Travel and Lodging
travel to Los Angeles, CA · in-kind
Company’s description;4269430;AHM;11356658
$472
Nov 13, 2025Viiv Healthcare Company
Nov 13, 2025
Travel and Lodging
CABENUVA · HIV · travel to Columbia, MO
$311
Nov 10, 2025Gilead Sciences, Inc.
Nov 10, 2025
Travel and Lodging
travel to Los Angeles, CA · in-kind
Company’s description;4269441;AHM;11356658
$1,350
Oct 17, 2025Gilead Sciences, Inc.
Oct 17, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4285780;GTF;11356658
$590
Oct 8, 2025Gilead Sciences, Inc.
Oct 8, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s description;4264060;AHM;11356658
$2,950
Oct 7, 2025Viiv Healthcare Company
Oct 7, 2025
Travel and Lodging
travel to Atlanta, GA · in-kind
$238
Sep 30, 2025Gilead Sciences, Inc.
Sep 30, 2025
Travel and Lodging
Biktarvy · HIV · travel to Kansas City, MO · in-kind
Company’s description;4259717;AHM;11356658
$185
Sep 30, 2025Gilead Sciences, Inc.
Sep 30, 2025
Travel and Lodging
Biktarvy · HIV · travel to Kansas City, MO · in-kind
Company’s description;4259547;AHM;11356658
$20.00
Sep 29, 2025Viiv Healthcare Company
Sep 29, 2025
Travel and Lodging
CABENUVA · HIV · travel to Wichita, KS
$188
Sep 18, 2025Viiv Healthcare Company
Sep 18, 2025
Consulting Fee$2,275
Sep 11, 2025Gilead Sciences, Inc.
Sep 11, 2025
Travel and Lodging
Biktarvy · HIV · travel to Omaha, NE · in-kind
Company’s description;4176712;AHM;11356658
$438
Sep 11, 2025Gilead Sciences, Inc.
Sep 11, 2025
Travel and Lodging
Biktarvy · HIV · travel to Omaha, NE · in-kind
Company’s description;4176022;AHM;11356658
$38.50
Sep 10, 2025Viiv Healthcare Company
Sep 10, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$3,900
Sep 9, 2025Gilead Sciences, Inc.
Sep 9, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4259721;AHM;11356658
$3,840
Sep 4, 2025Gilead Sciences, Inc.
Sep 4, 2025
Travel and Lodging
Biktarvy · HIV · travel to Kansas City, MO · in-kind
Company’s description;4259897;AHM;11356658
$188
Aug 21, 2025Viiv Healthcare Company
Aug 21, 2025
Travel and Lodging
CABENUVA · HIV · travel to Wichita, KS · in-kind
$1,328
Aug 21, 2025Viiv Healthcare Company
Aug 21, 2025
Travel and Lodging
CABENUVA · HIV · travel to Wichita, KS · in-kind
$127
Aug 14, 2025Viiv Healthcare Company
Aug 14, 2025
Travel and Lodging
travel to Washington, DC · in-kind
$242
Aug 12, 2025Gilead Sciences, Inc.
Aug 12, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4176334;AHM;11356658
$5,020
Aug 12, 2025Viiv Healthcare Company
Aug 12, 2025
Consulting Fee$2,600
Aug 11, 2025Gilead Sciences, Inc.
Aug 11, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4257566;AHM;11356658
$2,065
Aug 7, 2025Gilead Sciences, Inc.
Aug 7, 2025
Travel and Lodging
Biktarvy · HIV · travel to Omaha, NE · in-kind
Company’s description;4177105;AHM;11356658
$370
Jul 23, 2025Viiv Healthcare Company
Jul 23, 2025
Travel and Lodging
CABENUVA · HIV · travel to Springfield, IL
$302
Jul 23, 2025Viiv Healthcare Company
Jul 23, 2025
Travel and Lodging
CABENUVA · HIV · travel to Kansas City, MO
$199
Jul 21, 2025Viiv Healthcare Company
Jul 21, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$2,600
Jul 18, 2025Viiv Healthcare Company
Jul 18, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$2,600
Jul 14, 2025Viiv Healthcare Company
Jul 14, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$2,600
Jul 14, 2025Viiv Healthcare Company
Jul 14, 2025
Travel and Lodging
CABENUVA · HIV · travel to Saint Louis, MO
$188
Jun 25, 2025Gilead Sciences, Inc.
Jun 25, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s description;4128237;AHM;11356658
$1,480
Jun 25, 2025Viiv Healthcare Company
Jun 25, 2025
Travel and Lodging
CABENUVA · HIV · travel to Kansas City, MO · in-kind
$242
Jun 23, 2025Viiv Healthcare Company
Jun 23, 2025
Travel and Lodging
CABENUVA · HIV · travel to Springfield, IL · in-kind
$412
Jun 18, 2025Viiv Healthcare Company
Jun 18, 2025
Travel and Lodging
travel to Washington, DC · in-kind
$337
Jun 18, 2025Viiv Healthcare Company
Jun 18, 2025
Travel and Lodging
travel to Washington, DC · in-kind
$42.18
Jun 17, 2025Viiv Healthcare Company
Jun 17, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$1,300
Jun 2, 2025Viiv Healthcare Company
Jun 2, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$7,150
Jun 2, 2025Viiv Healthcare Company
Jun 2, 2025
Compensation for services other than consulting (speaking, faculty)
CABENUVA · HIV
$2,600
May 20, 2025Viiv Healthcare Company
May 20, 2025
Travel and Lodging
CABENUVA · HIV · travel to Columbia, MO
$303
May 20, 2025Viiv Healthcare Company
May 20, 2025
Travel and Lodging
CABENUVA · HIV · travel to Columbia, MO
$8.00
May 14, 2025Gilead Sciences, Inc.
May 14, 2025
Travel and Lodging
Biktarvy · HIV · travel to Dallas, TX
Company’s description;4027766;GTF;11356658
$33.60
Apr 21, 2025Gilead Sciences, Inc.
Apr 21, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4027423;GTF;11356658
$6,750
Apr 16, 2025Gilead Sciences, Inc.
Apr 16, 2025
Travel and Lodging
Biktarvy · HIV · travel to Kansas City, MO · in-kind
Company’s description;4098491;AHM;11356658
$186
Apr 4, 2025Gilead Sciences, Inc.
Apr 4, 2025
Travel and Lodging
Biktarvy · HIV · travel to Dallas, TX · in-kind
Company’s description;4027523;GTF;11356658
$330
Apr 4, 2025Gilead Sciences, Inc.
Apr 4, 2025
Travel and Lodging
Biktarvy · HIV · travel to Dallas, TX · in-kind
Company’s description;4027384;GTF;11356658
$101
Apr 3, 2025Gilead Sciences, Inc.
Apr 3, 2025
Travel and Lodging
Biktarvy · HIV · travel to Dallas, TX · in-kind
Company’s description;4027524;GTF;11356658
$933
Apr 3, 2025Gilead Sciences, Inc.
Apr 3, 2025
Travel and Lodging
Biktarvy · HIV · travel to Dallas, TX · in-kind
Company’s description;4027484;GTF;11356658
$296
Mar 31, 2025Gilead Sciences, Inc.
Mar 31, 2025
Consulting Fee
Company’s description;4146878;VEM US;11356658
$1,740
Mar 18, 2025Gilead Sciences, Inc.
Mar 18, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4113469;AHM;11356658
$3,840
Mar 6, 2025Gilead Sciences, Inc.
Mar 6, 2025
Consulting Fee
Company’s description;4146842;VEM US;11356658
$1,740
Feb 28, 2025Viiv Healthcare Company
Feb 28, 2025
Travel and Lodging
travel to Hollywood, FL · in-kind
$945
Feb 10, 2025Gilead Sciences, Inc.
Feb 10, 2025
Compensation for services other than consulting (speaking, faculty)
Biktarvy · HIV
Company’s description;4113475;AHM;11356658
$2,950
Jan 22, 2025Viiv Healthcare Company
Jan 22, 2025
Travel and Lodging
travel to Hollywood, FL · in-kind
$1,037
Jan 22, 2025Viiv Healthcare Company
Jan 22, 2025
Travel and Lodging
travel to Hollywood, FL · in-kind
$41.79

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Missouri →

Industry-funded research

Named as a principal investigator on 6 industry-funded studies in 2025, from 4 companies. The companies reported $498,569 in research payments for these studies, mostly to the institutions running them.

  • ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
    Mannkind Corporation · Terminated · NCT06418711
  • ACCELERATE a Multisite Prospective Hybrid (Effectiveness-implementation) Type 2 Design, Single-arm, Mixed-methods Study of a Simplified Accelerated ART Initiation Protocol for People With HIV Who Are Out of Care.
    Gilead Sciences, Inc.
  • A phase 2B multicenter, randomized, open-label study comparing the eff
    Viiv Healthcare Company
  • Reparixin 1200 mg three times a day as add-on therapy to standard of care to limit disease progression in hospitalised adult patients with COVID-19 and other community-acquired pneumonia. A multinational, multicentre,…
    Dompe Farmaceutici S.p.a.
  • Phase 2, proof-of-concept, randomized, double-blinded, placebo-controlled, multicenter study to assess efficacy and safety of reparixin as add-on therapy to standard of care in adult patients with Acute Respiratory …
    Dompe Farmaceutici S.p.a.
  • A phase 4, randomized, open-label, two-arm study evaluating implementa
    Viiv Healthcare Company

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Internal Medicine clinicians in Columbia

Sources

NPI registry (CMS NPPES, November 2026; record last updated October 5, 2022), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1235486705. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.